As these recommendations are based on expert recommendations, and have not been proven on small specimens, we propose to evaluate the value of the combination of anti-CK7/CK20 immunohistochemistry on small specimens in a retrospective cohort study of patients with clinically suspected primary lung carcinoma. This evidence concerns the gene KRT7 and lung carcinoma.